This article was originally published in The Gray Sheet
Collamer foldable intraocular lens gains FDA market go-ahead. Made out of a non-silicone material shown to be "extremely biocompatible," the replacement lens for cataract patients allows for corrections between -4 and +33 diopters and "is the only IOL that varies in length to accommodate the natural shape of the human eye," Staar maintains
You may also be interested in...
As the global shut-down caused by the coronavirus pandemic continues, sponsors are rushing to adapt clinical trials that can move to partial or completely remote monitoring, allowing patients to remain in their homes but continue to participate in studies. And the outbreak may have another silver lining for the biopharma industry, a chance to rebuild its reputation.
The arrival of SARS-CoV-2 has focused attention on a potential new way of making vaccines – one that promises to be quicker and cheaper than traditional methods and more reactive to novel virus outbreaks, but also one that remains to be validated.
Feature: Should consumers be turning to food supplements to support their immune systems during the COVID-19 epidemic? HBW Insight speaks to Professor David Richardson, scientific adviser to the Council for Responsible Nutrition UK and Nick Bennett, head of Nutrition at IVC Brunel Healthcare Ltd.